Intravenous amiodarone decreases the duration of atrial fibrillation associated with acute myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 15, Issue 2, 2001, Pages 155-160

  Kontoyannis, Dimitrios A ^a   Anastasiou Nana, Maria I ^a   Kontoyannis, Sofocles A ^a   Zaga, Afrodite K ^a   Nanas, John N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute myocardial infarction; Amiodarone; Atrial fibrillation

Indexed keywords

AMIODARONE; DIGOXIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINUS RHYTHM; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DIGOXIN; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 0034804393     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011127030014     Document Type: Article

References (45)

1. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction
2. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction
3. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
4. Circulatory consequences of changes in cardiac rhythm produced in patients by transthoracic direct current shock
5. Hemodynamic effects after reversion from atrial fibrillation to sinus rhythm by precordial shock
6. Management of atrial fibrillation
7. Quinidine syncope: Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias
8. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation
9. Torsade des pointes and aprindine
10. Digitalis in patients after myocardial infarction
11. Digitalis. Mechanisms of action and clinical use
12. Digitalis and allied cardiac glycosides
13. Is digoxin an independent risk factor for long-term mortality after acute myocardial infarction?
14. Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias
15. Amiodarone
16. Pharmacokinetics of amiodarone after intravenous and oral administration
17. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function
18. Amiodarone - An inhibitor of phospholipase activity: A comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine
19. The effect of amiodarone, a new antianginal drug, on cardiac muscle
20. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone
21. Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: Results of a prospective, placebo controlled study
22. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: Experimental study
23. Effects of amiodarone and desethylamiodarone on rabbit myocardial beta-adrenoceptors and serum thyroid hormones - Absence of relationship to serum and myocardial drug concentrations
24. Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodarone
25. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient
26. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: Results of a randomized, controlled study
27. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation
28. Intravenous amiodarone restores sinus rhythm in acute myocardial infarction complicated with atrial fibrillation
29. Low dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter
30. A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction
31. Intravenous amiodarone in atrial fibrillation complicating myocardial infarction
32. Efficacy of intravenously administered amiodarone for short-term control of serious arrhythmias
33. Digoxin for converting recent onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial
34. Using the right drug: A treatment algorithm for regular supraventricular tachycardias
35. Amiodarone: Intravenous loading for rapid suppression of complex ventricular arrhythmias
36. Use of intravenous amiodarone for emergency treatment of life threatening ventricular arrhythmias
37. Intravenous amiodarone for the rapid treatment of life threatening ventricular arrhythmias in critically ill patients with coronary artery disease
38. The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia
39. Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors
40. Hemodynamic effects of intravenous amiodarone
41. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation
42. Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence
43. Amiodarone-Biochemical aspects and haemodynamic effects
44. Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs
45. Pharmacokinetics and regional electrophysiological effects of intracoronary amiodarone administration